The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2017
The data on antimicrobial resistance in zoonotic and indicator bacteria in 2017, submitted by 28 EU Member States (MSs), were jointly analysed by EFSA and ECDC. Resistance in zoonotic Salmonella and Campylobacter from humans, animals and food, and resistance in indicator Escherichia coli as well as meticillin-resistant Staphylococcus aureus in animals and food were addressed, and temporal trends assessed. ‘Microbiological’ resistance was assessed using epidemiological cut-off (ECOFF) values; for some countries, qualitative data on human isolates were interpreted in a way which corresponds closely to the ECOFF-deﬁned ‘microbiological’ resistance.
Zoonoses: antimicrobial resistance shows no signs of slowing down
Data released today by the European Centre for Disease Prevention and Control (ECDC) and European Food Safety Authority (EFSA) reveal that antimicrobials used to treat diseases that can be transmitted between animals and humans, such as campylobacteriosis and salmonellosis, are becoming less effective.
More on the topic
Antimicrobial resistance of Salmonella, E. Coli and Campylobacter in humans, animals and food, country by country: data from 2017 – interactive infographic
See interactive infographicRead more
European Antibiotic Awareness Day Campaign Website
European Antibiotic Awareness Day (EAAD) is a European health initiative coordinated by ECDC, which provides a platform and support for national campaigns on the prudent use of antibiotics. Each year, EAAD is marked on 18 November. Visit the campaign website of EAAD.Read more
Zoonotic diseases: progress has stalled
12 Dec 2018 - There were only minor fluctuations in reported cases of three main zoonotic diseases in the European Union (EU) last year compared with 2016.
ECDC calls for continued action to address antimicrobial resistance in healthcare settings
15 Nov 2018 - On European Antibiotic Awareness Day, ECDC publishes the results of two point-prevalence surveys of healthcare-associated infections and antimicrobial use in hospitals and in long-term care facilities in the EU/EEA.